Moderna: FDA delaying decision on its shot for adolescents
CAMBRIDGE, Mass. — U.S. regulators are delaying their decision on Moderna’s COVID-19 vaccine for 12- to 17-year-olds while they study the rare risk of heart inflammation, the company said Sunday. The U.S. Food and Drug […]